1. Home
  2. PNTG vs ANAB Comparison

PNTG vs ANAB Comparison

Compare PNTG & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Pennant Group Inc.

PNTG

The Pennant Group Inc.

N/A

Current Price

$34.36

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

ANAB

AnaptysBio Inc.

N/A

Current Price

$63.44

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PNTG
ANAB
Founded
2019
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.3B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
PNTG
ANAB
Price
$34.36
$63.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
10
Target Price
$36.83
$68.10
AVG Volume (30 Days)
288.6K
477.1K
Earning Date
05-27-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
20.00
91.02
EPS
0.84
N/A
Revenue
$947,705,000.00
$234,603,000.00
Revenue This Year
$24.93
N/A
Revenue Next Year
$7.52
$43.04
P/E Ratio
$40.51
N/A
Revenue Growth
36.31
157.01
52 Week Low
$21.74
$15.32
52 Week High
$35.25
$66.66

Technical Indicators

Market Signals
Indicator
PNTG
ANAB
Relative Strength Index (RSI) 59.00 63.83
Support Level $27.34 $43.67
Resistance Level $35.00 N/A
Average True Range (ATR) 1.68 3.68
MACD 0.04 0.66
Stochastic Oscillator 82.68 73.68

Price Performance

Historical Comparison
PNTG
ANAB

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: